Projection of budgetary savings to US state Medicaid programs from reduced nursing home use due to an Alzheimers disease treatment

摘要

The approval of a disease‐modifying Alzheimer's disease (AD) treatment could provide relief to US state budgets that were hit hard by the COVID‐19 pandemic, as mostly Medicare would cover treatment cost, whereas Medicaid would see savings from reduced nursing home use.